Page 1102 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

78. Cunha BA. Clinical features of Rocky Mountain spotted fever. 99. Rubin SA. Radiographic spectrum of pleuropulmonary tularemia.
Lancet Infect Dis. 2008;8:143-144. AJR Am J Roentgenol. 1978;131:277-281.
79. Thorner AR, Walker DH, Petri WA Jr. Rocky mountain spotted 100. Sutinen S, Syrjala H. Histopathology of human lymph node
fever. Clin Infect Dis. 1998;27:1353-1359; quiz 60. tularemia caused by Francisella tularensis var palaearctica. Arch
80. Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect Pathol Lab Med. 1986;110:42-46.
Dis. 2007;7:724-732. 101. Bevanger L, Maeland JA, Kvan AI. Comparative analysis of anti-
81. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE Jr, bodies to Francisella tularensis antigens during the acute phase
Fritsche TR. Tick-borne diseases in the United States. N Engl J of tularemia and eight years later. Clin Diagn Lab Immunol.
Med. 1993;329:936-947. 1994;1:238-240.
82. O’Reilly M, Paddock C, Elchos B, Goddard J, Childs J, Currie M. 102. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and
Physician knowledge of the diagnosis and management of alternative agents for the treatment of tularemia: review of the
Rocky Mountain spotted fever: Mississippi, 2002. Ann N Y Acad literature. Clin Infect Dis. 1994;19:42-47.
Sci. 2003;990:295-301. 103. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features
83. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and and short-term outcomes of 144 patients with SARS in the
mortality in cases of Rocky Mountain spotted fever. Clin Infect greater Toronto area. JAMA. 2003;289:2801-2809.
Dis. 1995;20:1118-1121. 104. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of
84. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and manage- severe acute respiratory syndrome. Lancet. 2003;361:1319-1325.
ment of tickborne rickettsial diseases: Rocky Mountain spotted 105. Yu IT, Li Y, Wong TW, et al. Evidence of airborne transmission
fever, ehrlichioses, and anaplasmosis—United States: a practical of the severe acute respiratory syndrome virus. N Engl J Med.
guide for physicians and other health-care and public health 2004;350:1731-1739.
professionals. MMWR Recomm Rep. 2006;55:1-27. 106. Scales DC, Green K, Chan AK, et al. Illness in intensive care
85. Prentice MB, Rahalison L. Plague. Lancet. 2007;369:1196-1207. staff after brief exposure to severe acute respiratory syndrome.
86. Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated Emerg Infect Dis. 2003;9:1205-1210.
human plague in the Western US, 1977-1998. Clin Infect Dis. 107. Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions
2000;30:893-900. against droplets and contact in prevention of nosocomial trans-
87. Perry RD, Fetherston JD. Yersinia pestis—etiologic agent of mission of severe acute respiratory syndrome (SARS). Lancet.
plague. Clin Microbiol Rev. 1997;10:35-66. 2003;361:1519-1520.
88. Centers for Disease Control and Prevention (CDC). Human 108. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosoco-
plague–United States, 1993-1994. MMWR Morb Mortal Wkly mial outbreak of severe acute respiratory syndrome (SARS) in
Rep. 1994;43:242-246. Toronto, Canada. CMAJ. 2003;169:285-292.
89. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. Role 109. Cauchemez S, Fraser C, Van Kerkhove MD, et al. Middle East
of the Yersinia pestis plasminogen activator in the incidence respiratory syndrome coronavirus: quantification of the extent
of distinct septicemic and bubonic forms of flea-borne plague. of the epidemic, surveillance biases, and transmissibility. Lancet
Proc Natl Acad Sci U S A. 2006;103:5526-5530. Infect Dis. 2014;14:50-56.
90. Butler T. Yersinia infections: centennial of the discovery of the 110. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD,
plague bacillus. Clin Infect Dis. 1994;19:655-661; quiz 62-63. Fouchier RA. Isolation of a novel coronavirus from a man
with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:
91. Crook LD, Tempest B. Plague: a clinical review of 27 cases. Arch 1814-1820.
Intern Med. 1992;152:1253-1256.
111. Centers for Disease Control and Prevention (CDC). Update:
92. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biolog- Recommendations for Middle East respiratory syndrome
ical weapon: medical and public health management. Working coronavirus (MERS-CoV). MMWR Morb Mortal Wkly Rep.
Group on Civilian Biodefense. JAMA. 2000;283:2281-2290. 2013;62:557.
93. McCrumb FR Jr, Mercier S, Robic J, et al. Chloramphenicol and 112. Centers for Disease Control and Prevention (CDC). Update:
terramycin in the treatment of pneumonic plague. Am J Med. severe respiratory illness associated with a novel coronavirus–
1953;14:284-293. worldwide, 2012-2013. MMWR Morb Mortal Wkly Rep.
94. Cox SK, Everett ED. Tularemia, an analysis of 25 cases. Mo Med. 2013;62:194-195.
1981;78:70-74. 113. Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and
95. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as outcomes of critically ill patients with Middle East respi-
a biological weapon: medical and public health management. ratory syndrome coronavirus infection. Ann Intern Med.
JAMA. 2001;285:2763-2773. 2014;160(6):389-397.
96. Tularemia transmitted by insect bites–Wyoming, 2001-2003. 114. Gomersall CD, Joynt GM. Middle East respiratory syndrome:
MMWR Morb Mortal Wkly Rep. 2005;54:170-173. new disease, old lessons. Lancet. 2013;381:2229-2230.
97. Feldman KA, Enscore RE, Lathrop SL, et al. An outbreak of 115. Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral
primary pneumonic tularemia on Martha's Vineyard. N Engl J diagnosis of two cases of infection with Middle East Respiratory
Med. 2001;345:1601-1606. Syndrome coronavirus: a report of nosocomial transmission.
98. Evans ME, Gregory DW, Schaffner W, McGee ZA. Tularemia: Lancet. 2013;381:2265-2272.
a 30-year experience with 88 cases. Medicine (Baltimore). 116. Guery B, van der Werf S. Coronavirus: need for a therapeutic
1985;64:251-269. approach. Lancet Infect Dis. 2013;13:726-727.

Section05-O-ref.indd 3 1/20/2015 4:51:25 PM